Ebola Vaccine Registry Study

THIS STUDY IS NOW IN FOLLOW UP

What is the purpose of this study?

Eligible participants for this study have previously received an experimental Ebola vaccine- Ad26.ZEBOV and MVA-BN-Filo. The purpose of this study is to collect long-term safety data from these participants who received two experimental vaccines to prevent Ebola virus disease. This may contribute to the future development of an Ebola vaccine.

For further information, please see the Participant Information Sheet: Ebola Vaccine Registry Study PIS.pdf